Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
5.03
-0.10 (-1.95%)
At close: Nov 22, 2024, 4:00 PM
5.29
+0.26 (5.13%)
After-hours: Nov 22, 2024, 6:06 PM EST
Outlook Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 119 | 58 | 276 | 380 | 92 | 42 | |
| Market Cap Growth | -61.32% | -79.15% | -27.49% | 315.51% | 117.68% | -40.54% | |
| Enterprise Value | 120 | 59 | 260 | 372 | 73 | 48 | |
| Last Close Price | 5.03 | 4.42 | 24.40 | 43.40 | 14.40 | 29.80 | |
| PS Ratio | - | - | - | - | - | 5.16 | |
| PB Ratio | -2.06 | -3.98 | 31.58 | 82.58 | 32.40 | -3.91 | |
| P/TBV Ratio | - | - | 31.58 | 82.58 | 32.40 | - | |
| EV/Sales Ratio | - | - | - | - | - | 5.92 | |
| Debt / Equity Ratio | -0.39 | -2.46 | 1.25 | 2.58 | 1.71 | -1.39 | |
| Asset Turnover | - | - | - | - | - | 0.41 | |
| Quick Ratio | 0.75 | 0.50 | 0.88 | 2.14 | 0.84 | 0.45 | |
| Current Ratio | 1.07 | 0.66 | 1.39 | 3.19 | 1.13 | 0.67 | |
| Return on Equity (ROE) | - | - | -989.99% | -1430.33% | - | - | |
| Return on Assets (ROA) | -83.69% | -109.17% | -153.56% | -151.98% | -123.12% | -79.37% | |
| Return on Capital (ROIC) | - | -162.72% | -217.76% | -267.59% | -383.73% | -590.69% | |
| Earnings Yield | -79.04% | -102.55% | -23.94% | -13.97% | -38.48% | -82.07% | |
| FCF Yield | -54.25% | -74.72% | -20.54% | -14.26% | -34.72% | -77.80% | |
| Buyback Yield / Dilution | -32.01% | -17.96% | -38.91% | -110.43% | -298.84% | -268.84% | |
| Total Shareholder Return | -32.01% | -17.96% | -38.91% | -110.43% | -298.84% | -268.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.